Neuropharmacological Effects of Gastrodia Elata Blume

Gastrodia elata Blume, commonly known as Tianma, is a traditional herbal medicine with a long history of use in neurological disorders. Its principal bioactive constituent, gastrodin, together with related phenolic glycosides such as parishins and vanillyl alcohol, exerts a broad spectrum of neuropharmacological actions. Preclinical models have demonstrated anticonvulsant, analgesic, sedative and neuroprotective effects across conditions including epilepsy, stroke, chronic pain and neurodegenerative diseases. Mechanistically, these compounds modulate ion channels and neurotransmitter systems, suppress oxidative stress and inflammatory cascades, inhibit microglial activation, stabilise mitochondrial function and up-regulate endogenous neurotrophins. Recent advances also reveal protective roles in astrocytes via activation of antioxidant transcription factors. Collectively, this body of work underscores the global significance of G. elata metabolites as leads for novel therapeutics targeting central nervous system pathologies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Neuropharmacological Effects of Gastrodia Elata Blume publication trend

The graph below shows the total number of articles in neuropharmacological effects of gastrodia elata blume across all publications each year (not limited to Nature Index journals).

Technical terms

Gastrodin: A phenolic glycoside and principal bioactive constituent of G. elata, responsible for many of its neuropharmacological effects.

Oxidative stress: A condition arising from an imbalance between reactive oxygen species production and antioxidant defences, leading to cellular damage.

Microglial activation: The process by which resident immune cells in the central nervous system adopt an inflammatory phenotype, releasing cytokines and reactive species.

Astrocyte: A type of glial cell in the brain that supports neuronal health, regulates neurotransmission and contributes to antioxidant defence.

Allodynia: Pain elicited by normally non-painful stimuli, indicative of altered sensory processing.

Hyperalgesia: An enhanced response to stimuli that are typically painful, often associated with nerve dysfunction.

Nrf2: Nuclear factor erythroid 2-related factor 2, a transcription factor that orchestrates cellular antioxidant responses.

References

1. A Review on Central Nervous System Effects of Gastrodin. Frontiers in Pharmacology (2018).
2. Neuropharmacological Potential of Gastrodia elata Blume and Its Components. Evidence-based Complementary and Alternative Medicine (2015).
3. Gastrodin Inhibits Allodynia and Hyperalgesia in Painful Diabetic Neuropathy Rats by Decreasing Excitability of Nociceptive Primary Sensory Neurons. PLOS ONE (2012).
4. Gastrodin exerts robust neuroprotection in the postischemic brain via its protective effect against Zn2+-toxicity and its anti-oxidative effects in astrocytes. Animal Cells and Systems (2018).